We’re working on a document that describes the minimum and ideal characteristics of tools that predict the risk for pre-eclampsia in pregnant women. This type of document is called a target product profile or TPP.
This TPP will help people design and develop effective and affordable tools that more accurately predict pre-eclampsia in pregnant women. It aims to help improve maternal health outcomes globally.
We would like your feedback on this document. Read the draft TPP (DOCX 123 KB), and share your thoughts in this survey.
The document is developed in collaboration with Concept Foundation.
![](/media/y1wmbfa0/dscf7074-smaller-crop.jpg?quality=100)
Accurately predicting risk for pre-eclampsia
Pre-eclampsia is a complication of pregnancy that can happen after the 20th week of gestation. It is characterised by high blood pressure and signs that other organs, like the kidneys and liver, may not be working properly. It is a leading cause of global maternal and newborn deaths with an estimated 4.6% of pregnant women experiencing the condition (Source: European Journal of Obstetrics & Gynecology and Reproductive Biology).
In the past, medical professionals have looked at a mother’s medical history to determine their risk of pre-eclampsia. This method is not very effective at finding women who are at increased risk of developing the condition. Recently, new and better ways to screen for pre-eclampsia have been developed. These methods are more accurate at predicting which women may develop pre-eclampsia.
Why we need more tools to predict pre-eclampsia risk
Many places including low-resource settings still look at medical history to determine pre-eclampsia risk. This is because it can be hard to implement newer methods. Reasons include limited availability of trained health workers and inadequate infrastructure. Many women in these settings also do not start pregnancy care early on. We need new ways of measuring risk for pre-eclampsia for all women. They must be accurate, affordable, and best meet the needs of pregnant women in diverse settings.
Our TPP document describes the minimum and ideal characteristics of tools that accurately predict the risk for pre-eclampsia in pregnant women.
Your views on pre-eclampsia risk screening tools
We’re looking for feedback from different experts to improve this TPP. We want to define the characteristics of a pre-eclampsia risk screening tool that best meets global health needs.
We need your input. This survey will ask you to rate your agreement on the variables in the new TPP. It will take approximately 15 minutes to complete.
Your responses will be confidential. We do not collect identifying information such as your name, email address or IP address. You can withdraw from the survey at any time by closing your browser before completing all the questions.
More information
For more information, please contact annie.mcdougall@burnet.edu.au
Collaborators
Funding partners
Burnet project team
Meet the project team. Together, we are translating research into better health, for all.